Magnetocardiography-Guided Management of an Unusual Case of Isoimmune Complete Atrioventricular Block Complicated by Ventricular TachycardiaDas B.a · Cuneo B.F.b · Ovadia M.b · Strasburger J.F.c · Johnsrude C.a · Wakai R.T.d
aDepartment of Pediatrics, Division of Pediatric Cardiology, University of Louisville, Louisville, Ky., bThe Heart Institute of Children, University of Illinois at Chicago School of Medicine, Chicago, Ill., cDepartment of Pediatrics, Division of Pediatric Cardiology, Medical College of Wisconsin, Milwaukee, Wisc., and dDepartment of Medical Physics, University of Wisconsin Madison, Madison, Wisc., USA
Bettina Cuneo, MD
The Heart Institute for Children, Hope Children’s Hospital
4440 W. 95th Street
Oak Lawn, IL 60645 (USA)
Tel. +1 708 684 580, Fax +1 708 648 4068, E Mail firstname.lastname@example.org
Do you have an account?
A fetus who was diagnosed at 25 weeks of gestation with isoimmune AV block presented at 34 weeks with a precipitous fall in ventricular rate and periods of tachycardia. Magnetocardiography revealed the tachycardia to be ventricular. After delivery, nonsustained ventricular tachycardia continued. The baby then successfully paced, and at higher ventricular rates the tachycardia resolved. Five years later the child has normal ventricular function and is doing well.
© 2008 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.